lobbying_activities: 3481803

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3481803	5afde9cc-87fa-4028-ae28-2de655ac7e41	Q4	LMH STRATEGIC SOLUTIONS	401108183	GLAXOSMITHKLINE LLC	2025	fourth_quarter	PHA	Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2026-01-12T17:06:04-05:00